Wang et al describe the discovery, development, and preclinical evaluation of a novel T cell-dependent bispecific #antibody targeting tumor-associated antigen LY6G6D for the treatment of #ColorectalCancer. https://t.co/Z3RkJRCKta https://t.co/SJcOqiK8v6
RT @BertrandBio: Recent $ROG $RHHBY paper of in vitro+🐭data on a bispec tgting a novel CRC TAA, namely LY6G6D. Apparently relatively clean…
Long $RHHBY …
Recent $ROG $RHHBY paper of in vitro+🐭data on a bispec tgting a novel CRC TAA, namely LY6G6D. Apparently relatively clean target. Novel Anti-LY6G6D/CD3 T Cell-Dependent Bispecific Antibody for the Treatment of Colorectal Cancer https://t.co/yV4GTiBIAn ht